Huntington National Bank Reduces Stock Position in Cooper Companies Inc (NYSE:COO)

Share on StockTwits

Huntington National Bank lowered its position in shares of Cooper Companies Inc (NYSE:COO) by 9.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,719 shares of the medical device company’s stock after selling 839 shares during the period. Huntington National Bank’s holdings in Cooper Companies were worth $2,190,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in COO. Harvest Fund Management Co. Ltd purchased a new stake in shares of Cooper Companies in the 1st quarter worth about $34,000. Squar Milner Financial Services LLC lifted its position in shares of Cooper Companies by 19.4% in the 1st quarter. Squar Milner Financial Services LLC now owns 326 shares of the medical device company’s stock worth $89,000 after purchasing an additional 53 shares during the period. CSat Investment Advisory L.P. lifted its position in shares of Cooper Companies by 53.6% in the 1st quarter. CSat Investment Advisory L.P. now owns 324 shares of the medical device company’s stock worth $89,000 after purchasing an additional 113 shares during the period. Fifth Third Bancorp lifted its position in shares of Cooper Companies by 21.7% in the 1st quarter. Fifth Third Bancorp now owns 421 shares of the medical device company’s stock worth $116,000 after purchasing an additional 75 shares during the period. Finally, Arden Trust Co purchased a new stake in shares of Cooper Companies in the 1st quarter worth about $120,000. 88.09% of the stock is owned by institutional investors and hedge funds.

In related news, SVP Agostino Ricupati purchased 1,000 shares of Cooper Companies stock in a transaction dated Thursday, June 11th. The stock was purchased at an average cost of $281.47 per share, for a total transaction of $281,470.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Holly R. Sheffield purchased 355 shares of Cooper Companies stock in a transaction dated Wednesday, July 8th. The stock was bought at an average price of $280.00 per share, with a total value of $99,400.00. Following the completion of the purchase, the executive vice president now directly owns 1,285 shares of the company’s stock, valued at $359,800. The disclosure for this purchase can be found here. Insiders bought 3,235 shares of company stock valued at $908,298 over the last quarter. Company insiders own 1.40% of the company’s stock.

Several equities research analysts have recently commented on COO shares. Wells Fargo & Co dropped their target price on shares of Cooper Companies from $388.00 to $329.00 and set an “overweight” rating for the company in a research report on Thursday, May 21st. Stephens lifted their price target on shares of Cooper Companies from $300.00 to $325.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th. Jefferies Financial Group lowered their price target on shares of Cooper Companies from $360.00 to $340.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Raymond James lowered their price target on shares of Cooper Companies from $340.00 to $330.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. Finally, Oppenheimer started coverage on shares of Cooper Companies in a research report on Friday, June 5th. They set a “hold” rating and a $330.00 price target for the company. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Cooper Companies has an average rating of “Buy” and an average target price of $330.25.

NYSE:COO opened at $282.93 on Friday. The firm has a market cap of $15.09 billion, a P/E ratio of 26.37, a P/E/G ratio of 3.04 and a beta of 0.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.58 and a current ratio of 1.14. Cooper Companies Inc has a fifty-two week low of $236.68 and a fifty-two week high of $365.68. The firm has a 50-day simple moving average of $288.34 and a two-hundred day simple moving average of $307.54.

Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.51 earnings per share for the quarter, missing analysts’ consensus estimates of $2.29 by ($0.78). The firm had revenue of $524.90 million for the quarter, compared to the consensus estimate of $604.78 million. Cooper Companies had a net margin of 13.50% and a return on equity of 14.67%. The firm’s revenue for the quarter was down 19.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.94 earnings per share. On average, equities research analysts predict that Cooper Companies Inc will post 8.45 EPS for the current year.

The business also recently declared a Semi-Annual dividend, which will be paid on Friday, August 7th. Stockholders of record on Thursday, July 23rd will be paid a $0.03 dividend. The ex-dividend date is Wednesday, July 22nd. Cooper Companies’s dividend payout ratio is presently 0.49%.

Cooper Companies Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: Earnings Per Share

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

 

Latest News

Different Types of Research Papers
Different Types of Research Papers
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing


 
© 2006-2020 BBNS.